Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Cash on Hand 2010-2025 | EVO

Evotec AG cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Evotec AG Annual Cash on Hand
(Millions of US $)
2024 $429
2023 $654
2022 $757
2021 $1,015
2020 $551
2019 $358
2018 $176
2017 $103
2016 $140
2015 $149
2014 $118
2013 $128
2012 $83
2011 $87
2010 $93
2009 $81
Evotec AG Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $391
2024-12-31 $429
2024-09-30 $333
2024-06-30 $322
2024-03-31 $554
2023-09-30 $668
2023-06-30 $677
2022-12-31 $757
2022-09-30 $830
2022-06-30 $945
2022-03-31 $959
2021-12-31 $1,015
2021-09-30 $492
2021-06-30 $541
2021-03-31 $555
2020-12-31 $551
2020-09-30 $298
2020-06-30 $304
2020-03-31 $354
2019-12-31 $358
2019-09-30 $314
2019-06-30 $384
2019-03-31 $161
2018-12-31 $176
2018-09-30 $196
2018-06-30 $131
2018-03-31 $97
2017-12-31 $103
2017-09-30 $104
2017-06-30 $206
2017-03-31 $197
2016-12-31 $140
2016-09-30 $134
2016-06-30 $134
2016-03-31 $135
2015-12-31 $149
2015-09-30 $154
2015-06-30 $157
2015-03-31 $108
2014-12-31 $118
2014-09-30 $121
2014-06-30 $117
2014-03-31 $124
2013-12-31 $128
2013-09-30 $112
2013-06-30 $73
2013-03-31 $80
2012-12-31 $83
2012-09-30 $70
2012-06-30 $69
2012-03-31 $75
2011-12-31 $87
2011-09-30 $81
2011-06-30 $77
2011-03-31 $90
2010-12-31 $93
2010-09-30 $87
2010-06-30 $83
2010-03-31 $75
2009-12-31 $81
2009-09-30 $79
2009-06-30 $87
2009-03-31 $91
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.513B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.683B 31.42
Zoetis (ZTS) United States $67.115B 25.04
Daiichi Sankyo, - (DSNKY) Japan $46.355B 23.76
Takeda Pharmaceutical (TAK) Japan $45.533B 9.06
BeOne Medicines - (ONC) Cayman Islands $32.278B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.052B 0.00
Summit Therapeutics (SMMT) United States $20.386B 0.00
Merck (MKKGY) Germany $16.931B 12.40
Shionogi (SGIOY) Japan $15.006B 15.03
United Therapeutics (UTHR) United States $13.448B 11.90
Neurocrine Biosciences (NBIX) United States $13.233B 45.33
Orion OYJ (ORINY) Finland $11.504B 27.72
IPSEN (IPSEY) France $10.846B 0.00
Stevanato Group S.p.A (STVN) Italy $7.865B 48.09
Corcept Therapeutics (CORT) United States $7.333B 59.61
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.553B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.531B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.296B 0.00
Hypermarcas (HYPMY) Brazil $2.971B 19.54
Crinetics Pharmaceuticals (CRNX) United States $2.837B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.629B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.561B 13.85
Catalyst Pharmaceuticals (CPRX) United States $2.537B 8.89
Centessa Pharmaceuticals (CNTA) United Kingdom $2.031B 0.00
Ocular Therapeutix (OCUL) United States $1.924B 0.00
Endo (NDOI) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.802B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.728B 0.00
Guardian Pharmacy Services (GRDN) United States $1.313B 0.00
Harrow (HROW) United States $1.279B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.201B 24.03
Dyne Therapeutics (DYN) United States $1.058B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.048B 0.00
Ardelyx (ARDX) United States $1.024B 0.00
Enliven Therapeutics (ELVN) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $1.008B 5.43
Akebia Therapeutics (AKBA) United States $0.943B 0.00
ProKidney (PROK) United States $0.902B 0.00
Cronos Group (CRON) Canada $0.795B 0.00
Xeris Biopharma Holdings (XERS) United States $0.793B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.712B 0.00
KalVista Pharmaceuticals (KALV) United States $0.678B 0.00
Xencor (XNCR) United States $0.643B 0.00
Organogenesis (ORGO) United States $0.637B 0.00
Relay Therapeutics (RLAY) United States $0.634B 0.00
Zevra Therapeutics (ZVRA) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
USANA Health Sciences (USNA) United States $0.586B 11.77
Tourmaline Bio (TRML) United States $0.581B 0.00
Theravance Biopharma (TBPH) United States $0.553B 0.00
Bioventus (BVS) United States $0.536B 13.60
Oruka Therapeutics (ORKA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.515B 10.76
Savara (SVRA) United States $0.460B 0.00
Aquestive Therapeutics (AQST) United States $0.397B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.357B 9.66
Tonix Pharmaceuticals Holding (TNXP) United States $0.348B 0.00
Altimmune (ALT) United States $0.327B 0.00
AleAnna (ANNA) United States $0.321B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Esperion Therapeutics (ESPR) United States $0.315B 0.00
Nanobiotix S.A (NBTX) France $0.313B 0.00
Nektar Therapeutics (NKTR) United States $0.293B 0.00
Heron Therapeutics (HRTX) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 24.97
OmniAb (OABI) United States $0.252B 0.00
Larimar Therapeutics (LRMR) United States $0.233B 0.00
MediWound (MDWD) Israel $0.215B 0.00
4D Molecular Therapeutics (FDMT) United States $0.215B 0.00
Liminatus Pharma (LIMN) United States $0.210B 0.00
Lyell Immunopharma (LYEL) United States $0.203B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Journey Medical (DERM) United States $0.179B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.147B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Metagenomi (MGX) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.69
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Surrozen (SRZN) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Wellgistics Health (WGRX) United States $0.075B 0.00
Inotiv (NOTV) United States $0.074B 0.00
Avalo Therapeutics (AVTX) United States $0.071B 0.00
Rafael Holdings (RFL) United States $0.071B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.063B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
BioNxt Solutions (BNXTF) Canada $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.67
Klotho Neurosciences (KLTO) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.037B 0.00
Plus Therapeutics (PSTV) United States $0.035B 0.00
Incannex Healthcare (IXHL) Australia $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
CASI Pharmaceuticals (CASI) China $0.020B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.56
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
BioVie (BIVI) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00